Abstract
This year marks the end of the second decade of research on post-transfusion non- A, non-B hepatitis (or PT-NANBH), now primarily known to be caused by hepatitis C virus (HCV; CHOO et al. 1989). Approximately 10 years ago, the successful molecular cloning of HCV was publicly announced and ushered in a new era of epidemiological, medical, and laboratory research virtually unparalleled by any other area in virology. During the last 10 years, according to a January 1998 search of the NLM-Medline-PubMed database, more than 14,000 publications listing hepatitis C have been cited. This astounding growth was a result of the diligent and persistent efforts of at least two major laboratories and the accumulated knowledge generated by many other scientists in other laboratories who struggled to isolate, characterize, and clone the major agent (virus) responsible for PT-NANBH. One Australian scientist who previously worked in the field of PT-NANBH remarked (in 1990) that “over 80 laboratories at one time or another worked on non-A, non-B hepatitis...and that by the end of 1987 virtually only three or four laboratories were seriously pursuing research in this area.” This perspective highlights the extremely frustrating nature of earlier research in the field of PT-NANBH and reveals the trend of a rapidly diminishing number of active laboratories over time during the mid-1980s.
Chapter PDF
Similar content being viewed by others
Keywords
- Ultrastructural Alteration
- Electron Microscopic Evidence
- Viral Interference
- Hepatocyte Cytoplasm
- Maize Rough Dwarf Virus
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Aach RD, Lander JJ, Miller WV, Kahn RA, Gitnick GL, Hollinger FB, Werch J, Szmuness W, Stevens CE, Kellner AK, Weiner JM, Mosley JW (1978) Transfusion-transmitted viruses: interim analysis of hepatitis among transfused and non-transfused patients. In: Vyas GN, Cohen SH (eds) Viral hepatitis, a contemporary assessment of etiology, epidemiology, pathogenesis, and prevention. Franklin Institute Press, Philadelphia, pp 383–396
Alter HJ, Bradley DW (1995) Non-A, non-B hepatitis unrelated to the hepatitis C virus (Non-ABC). Semin Liver Dis 15:110–120
Alter HJ, Holland PV, Morrow AG, Purcell RH, Feinstone SM, Moritsugu Y (1975) Clinical and serological analysis of transfusion-transmitted hepatitis. Lancet 2:838–841
Alter HJ, Purcell RH, Holland PV, Popper H (1978) Transmissible agent in non-A, non-B hepatitis. Lancet 1:459–463
Alter HJ, Purcell RH, Feinstone SM, Tegtmeier GE (1982) Non-A, non-B hepatitis: its relationship to cytomegalovirus, to chronic hepatitis, and to direct and indirect test methods. In: Szmuness W, Alter HJ, Maynard JE (eds) Viral hepatitis 1981 international symposium. Franklin Institute Press, Philadelphia, pp 279–294
Alter HJ, Dienstag JL (1984) The evolving spectrum of non-A, non-B hepatitis. In: Chisari FV (ed) Advances in hepatitis research. Masson, New York, pp 281–292
Berman M, Alter HJ, Ishak KG, Purcell RH, Jones EA (1979) The chronic sequelae of non-A, non-B hepatitis. Ann Intern Med 91:1–6
Bianchi L, Gudat FG (1983) Histo- and immunopathology of viral hepatitis. In: Deinhardt F, Deinhardt J (eds) Viral hepatitis: laboratory and clinical science. Marcel Dekker, New York, pp 335–382
Bradley DW, Cook EH, Maynard JE, McCaustland KA, Ebert JW, Dolana GH, Petzel RA, Kantor RJ, Heilbrunn A, Fields HA, Murphy BL (1979) Experimental infection of chimpanzees with antihemophilic (Factor VIII) materials: recovery of virus-like particles associated with non-A, non-B hepatitis. J Med Virol 3:253–269
Bradley DW, Mayanard JE, Cook EH, Ebert JW, Gravelle CR, Tsiquaye KN, Kessler H, Zuckerman AJ, Miller MF, Ling C-M, Overby LR (1980) Non-A/non-B hepatitis in experimentally infected chimpanzees: cross-challenge and electron microscopic studies. J Med Virol 6:185–201
Bradley DW, Maynard JE, Popper H, Ebert JW, Cook EH, Fields HA, Kemler BJ (1981) Persistent non-A, non-B hepatitis in experimentally infected chimpanzees. J Infect Dis 143:210–218
Bradley DW, Maynard JE, Krawczynski KZ, Popper H, Cook EH, Gravelle CR, Ebert JW (1982) Non- A, non-B hepatitis in chimpanzees infected with a Factor Vili agent: evidence of persistent hepatic disease. In: Szmuness W, Alter HJ, Maynard JE (eds) Viral hepatitis 1981 international symposium. Franklin Institute Press, New York, pp 319–329
Bradley DW, Krawczynski KZ, Cook EH, Gravelle CR, Ebert JW, Maynard JE (1982) Recrudescence of non-A, non-B hepatitis in persistently infected chimpanzees. In: Hopkins R, Fileds S (eds) Viral hepatitis, 2nd international workshop. Nuclear Enterprises, Edinburgh, pp 43–48
Bradley DW, Maynard JE (1983) Non-A, non-B hepatitis: research progress and current perspectives. Dev Biol Stand 54:463–473
Bradley DW, Maynard JE, Popper H, Cook, EH, Ebert JW, McCaustland KA, Schable CA, Fields HA (1983) Post-transfusion non-A, non-B hepatitis: physicochemical properties of two distinct agents. J Infect Dis 148:254–265
Bradley DW, Maynard JE, McCaustland KA, Murphy BL, Cook EH, Ebert JW (1983) Non-A, non-B hepatitis in chimpanzees: interference with acute hepatitis A virus and chronic hepatitis B virus infections. J Med Virol 11:207–213
Bradley DW, Schable CA, McCaustland KA, Cook EH, Murphy BL, Fields HA, Ebert JW, Wheeler CM, Maynard JE (1984) Hepatitis A virus: growth characteristics of in vivo and in vitro propagated wild and attenuated virus strains. J Med Virol 14:373–386
Bradley DW (1984) Transmission, etiology, and pathogenesis of viral hepatitis non-A, non-B in non- human primates. In: Chisari FV (ed) Advances in hepatitis research, chap 31. Masson, New York, pp 268–280
Bradley DW, McCaustland KA, Cook EH, Ebert JW, Maynard JE (1984) Non-A, non-B hepatitis is chimpanzees: effects of immunosuppression on course of disease and recovery of tubule-forming agent from infected liver. Viral hepatitis and liver disease, chap 39. Grune and Stratton, New York, pp 451–458
Bradley DW, McCaustland KA, Cook EH, Schable CA, Ebert JW, Maynard JE (1985a) Post-transfusion non-A, non-B hepatitis in chimpanzees: physicochemical evidence that the tubule forming agent is a small, enveloped virus. Gastroenterology 88:773–779
Bradley DW, Cook EH, Miller MF, Schaff Z, Gravelle CR, McCaustland KA, Maynard JE (1985b) Non-A, non-B hepatitis in experimentally infected chimpanzees: comparative morphology of virus- induced ultrastructural changes. In: Nishioka K, Blumber B, Ishida N, Koike K (eds) Hepatitis viruses and hepatocellular carcinoma: approaches through molecular biology and ecology. Academic, Tokyo, pp 225–250
Bradley DW, Andjaparidze A, Cook EH, McCaustland KA, Balayan M, Stetler H, Velazquez O, Robertson B, Humphrey C, Kane M, Weisfuse I (1988) Etiologic agent of enterically-transmitted non-A, non-B hepatitis. J Gen Virol 69:731–758
Bradley DW (1990) Hepatitis non-A, non-B viruses become identified as hepatitis C and E viruses. Prog Med Virol 37:101–135
Bradley DW, McCaustland KA, Krawczynski K, Spelbring J, Humphrey C, Cook EH (1991) Hepatitis C virus: buoyant density of the Factor VHI-derived isolate in sucrose. J Med Virol 34:206–208
Brotman B, Prince AM, Huima T, Richardson L, von den Ende MC, Pfeifer U (1983) Interference between non-A, non-B and hepatitis B virus infections in chimpanzees. J Med Virol 11:191–205
Brotman B, Prince AM, Huima T (1985) Non-A, non-B hepatitis: is there more than one single blood-borne strain? J Infect Dis 151:618–625
Brown P, Rohwer RG, Green EM, Gajdusek DC (1982) Effect of chemicals, heat, and histopathologic processing on high-infectivity hamster-adapted scrapie virus. J Infect Dis 145:683–687
Burk KH, Dreesman GR, Cabrai GA, Peters RL (1984) Long-term sequelae of non-A, non-B hepatitis in chimpanzees. Hepatology 4:808–816
Canese MG, Rizzetto M, Novara R, London WT, Purcell RH (1984) Experimental infection of chimpanzees with the HBsAg associated delta virus: an ultrastructural study. J Med Virol 13:63–72
Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359–362
Compans RW, Chopin PW (1973) Orthomyxoviruses and paramyxoviruses. In: Dalton AJ (ed) Ultra-structure of animal viruses and bacteriophages: an atlas. Academic, New York, pp 213–237
Craske J, Dilling N, Stern D (1975) An outbreak of hepatitis associated with intravenous injection of factor VIII concentrate. Lancet 2:221–223
Craske J, Spooner R (1978) Evidence for existence of two types of factor Vlll-associated non-B transfusion hepatitis. Lancet 2:1051–1052
Dales S, Eggers HJ, Tamm I, Palade GE (1965) Electron microscopic study of the formation of polio-virus. Virology 26:379–389
Dales S (1973) The structure and replication of reoviruses. In: Dalton AJ (ed) Ultrastructure of animal viruses and bacteriophages: an atlas. Academic, New York, pp 155–171
David-Ferreira JR, Manaker RA (1965) An electron microscopic study of the development of a mouse hepatitis in tissue culture cells. J Cell Biol 24:57–78
Davis CL, Hoofnagle JE, Waggoner JB (1984) Acute type A hepatitis during chronic hepatitis B virus infection: association of depressed hepatitis B virus replication with appearance of endogenous alpha interferon. J Med Virol 14:141–147
Dermott E (1985) Non-A, non-B hepatitis virus Lancet 1:170
Dienes H, Popper H, Arnold W, Lobeck H (1982) Histologic observations in human hepatitis non-A, non-B. Hepatology 2:562–571
Dienstag JL (1983) Non-A, non-B hepatitis II: experimental transmission, putative virus agents and markers, and prevention. Gastroenterology 85:743–768
Drucker J, Tabor E, Gerety RJ, Jackson D, Barker LF (1979) Simultaneous acute infection with hepatitis A and hepatitis B viruses in a chimpanzee. J Infect Dis 139:338–342
Fagan EA, Williams R (1984) Non-A, non-B hepatitis. Semin Liver Dis 4:314–335
Feinstone SM, Alter HJ, Dienes HP, Shimizu Y, Popper H, Blackmore D, Sly D, London WT, Purcell RH (1981) Non-A, non-B hepatitis in chimpanzees and marmosets. J Infect Dis 144:588–598
Feinstone SM, Michalik KS, Kamimura T, Alter HJ, London WT, Purcell RH (1983) Inactivation of hepatitis B virus and non-A, non-B hepatitis by chloroform. Infect Immun 41:816–821
Galbraith RM, Dienstag JL, Purcell RH, Gower PH, Zuckerman AJ, Williams R (1979) Non-A, non-B hepatitis associated with chronic liver disease in a haemodialysis unit. Lancet 1(8123):951–953
Guyer B, Bradley DW, Bryan JA, Maynard JE (1979) Non-A, non-B hepatitis among participants in a plasmapheresis stimulation program. J Infect Dis 139:634–640
Hampton RO, Phillips S, Knesek JE, Mink GI (1973) Ultrastructural cytology of pea leaves and roots infected by pea seedborne mosaic virus. Arch Gesamte Virusforsch 42:242–253
Harrison AK, Murphy FA, Gardner JJ (1982) Visceral target organs in systemic St. Louis encephalitis virus infections in hamsters. Exp Mol Pathol 37:292–304
Haugen RK (1979) Hepatitis after the transfusion of frozen red cells. N Engl J Med 301:393–395
He L-F, Alling D, Popkin T, Shapiro M, Alter HJ, Purcell RH (1987) Determining the size of non-A, non-B hepatitis virus by filtration. J Infect Dis 156:636–640
Hellings JA, Van Der Veen-Du Prie J, Snelting-Van Densen R, Stute R (1985) Preliminary results of transmission experiments of non-A, non-B hepatitis by mononuclear leucocytes from a chronic patient. J Virol Methods 10:321–326
Hindman SH, Maynard JE, Bradley DW, Denes AE, Berquist KR (1977) Simultaneous infections with type A and B hepatitis viruses. Am J Epidemiol 105:135–139
Hollinger FB, Gitnick GL, Aach RD, Szmuness W, Mosley JW, Stevens CE, Peters RL, Weiner JM, Werch JB, Lander JJ (1978) Non-A, non-B hepatitis transmission in chimpanzees: a project of the transfusion transmitted viruses study group. Intervirology 10:60–68
Hollinger FB, Mosley JW, Szmuness W, Aach RD, Peters RL, Stevens C (1980) Transfusion-transmitted viruses study: experimental evidence for two non-A, non-B hepatitis agents. J Infect Dis 142:400–407
Hollinger FB, Dolana G, Thomas W, Gyorkey F (1984) Reduction in risk of hepatitis transmission by heat-treatment of a human factor VIII concentrate. J Infect Dis 150:250–262
Hoofnagle JH, Alter HJ (1984) Chronic viral hepatitis. In: Vyas GN, Dienstag JL, Hoofnagle JH (eds) Viral hepatitis and liver disease. Grune and Stratton, New York, pp 97–113
Hooks JJ, Gibbs CJ (1975) The foamy viruses. Bacteriol Rev 39:169–185
Hruby MA, Schauf V (1978) Transfusion-related short-incubation hepatitis in hemophilic patients. JAMA 240:1355–1357
Iwarson S, Schaff Z, Mitchell F, Gerety RJ (1985) Non-A, non-B hepatitis virus. Lancet 1:171
Koretz RL, Suffin SC, Gitnick GL (1976) Post-transfusion chronic liver disease. Gastroenterology 71:797–803
Liaw Y-F, Chu C-M, Chang-Chien C-S, Wu C-S (1982) Simultaneous acute infections with hepatitis non- A, non-B viruses. Dig Dis Sci 27:762–764
Linnen J, Wages J, Zhang_Keck Z-Y, Fry K, Krawczynski K, Alter H, Koonin E, Gallagher M, Alter M, Hadziyannis K, Karayiannis P, Fung K, Nakatsuji Y, Shih W-K, Young L, Piatak M, Hoover C, Fernandez J, Chen S, Zou J-C, Morris T, Hyams K, Ismay S, Lifson J, Hess G, Foung S, Thomas H, Bradley D, Margolis H, Kim J (1996) Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 271:505–508.
Merz PA, Somerville RA, Wisniewski HM, Manuelidis L, Manuelidis EE (1983) Scrapie associated fibrils in Creutzfeldt-Jakob disease. Nature 306:474
Miyamoto H, Okamoto H, Sato K, Tanaka T, Mishiro S (1992) Extraordinarily low density hepatitis C virus estimated by sucrose density gradient centrifugation and the polymerase chain reaction. J Gen Virol 73:715–718
Monath TP, Cropp CB, Harrison AK (1983) Mode of entry of a neurotropic arbovirus into the central nervous system: reinvestigation of an old controversy. Lab Invest 48:399–10
Mosley JW, Redeker AG, Feinstone SM, Purcell RH (1977) Multiple hepatitis viruses in multiple attacks of acute viral hepatitis. N Engl J Med 296:75–78
Norkrans G, Frosner G, Hermodsson S, Iwarson S (1980) Multiple hepatitis attacks in drug addicts. JAMA 243:1056–1058
Pfeifer U, Thomssen R, Legier K, Böttcher Y, Gerlick W, Weinmann E, Klinge O (1980) Experimental non-A, non-B hepatitis: four types of cytoplasmic alteration in hepatocytes of infected chimpanzees. Virchows Arch B Cell Pathol 33:233–243
Prince AM, Brotman B, Grady GF, Kuhns WJ, Hazzi C, Levine RW, Millian SJ (1974) Long-incubation post-transfusion hepatitis without serological evidence of exposure to hepatitis-B virus. Lancet 2:241–246
Prince AM, Huima T, Williams BA, Bardina L, Brotman B (1984) Isolation of a virus from chimpanzee liver cell cultures inoculated with sera containing the agent of non-A, non-B hepatitis. Lancet 2:1071–1075
Prince AM, Stephan W, Dichtelmuller H et al. (1985) Inactivation of the Hutchinson strain of non-A, non-B hepatitis virus by combined use of beta-propiolactone and ultraviolet irradiation. J Med Virol 16:119–125
Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216:136–144
Prusiner SB, Groth DF, Bolton DC, Kent SB, Hood LE (1984) Purification and structural studies of a major scrapie prion protein. Cell 38:127–134
Rakela JH, Redker AG (1979) Chronic liver disease after acute non-A, non-B viral hepatitis. Gastroenterology 77:1200–1202
Reyes GR, Purdy MA, Kim JP, Luk K-C, Young LM, Fry KE, Bradley DW (1990) Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 247:1335–1339
Roberts IM, Harrison BD (1970) Inclusion bodies and tubular structures in Chenopodium amar anticolor plants infected with strawberry latent ringspot virus. J Gen Virol 7:47–54
Seto B, Iwarson S, Coleman WG, Gerety RJ (1984) Detection of reverse transcriptase activity in association with the non-A, non-B hepatitis agent(s). Lancet 2:941–943
Shamoto M, Murakami S, Zenke T (1981) Adult T-cell leukemia in Japan: an ultrastructural study. Cancer 47:1804–1811
Shimizu YK, Feinstone SM, Purcell RH, Alter HJ, London WT (1979) Non-A, non-B hepatitis: ultra- structural evidence for two agents in experimentally infected chimpanzees. Science 205:197–200
Sidhu GS, Stahl RE, El-Sadr W, Zolla-Payner S (1983) Ultrastructural markers of AIDS. Lancet 1:990–991
Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Merhoff AS, Schlauder G, Desai SM, Mushawar IK (1995) Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1:564–569
Tabor E, Gerety RJ, Drucker JA, Seeff LB, Hoofnagle JH, Jackson DR, April M, Barker LF, Pineda- Tamondong G (1978) Transmission of non-A, non-B hepatitis from man to chimpanzee. Lancet 1:463–466
Tabor E, Seeff LB, Gerety RJ (1980) Chronic non-A, non-B hepatitis carrier state. N Engl J Med 303:139–143
Tabor E, Gerety RJ (1980) Inactivation of an agent of human non-A, non-B hepatitis by formalin. J Infect Dis 142:767–770
Tateda A, Kikuchi K, Numazaki Y, Shirachi R, Ishida N (1979) Non-A, non-B hepatitis in Japanese recipients of blood transfusions: clinical and serologic studies after the introduction of laboratory screening of donor blood to hepatitis B surface antigen. J Infect Dis 139:511–518
Tsiquaye KN, Zuckerman AJ (1979) New human hepatitis virus. Lancet 1:1135–1136
Tsiquaye KN, Byrd RG, Tovey G, Wyke RJ, Williams R, Zuckerman A J (1980) Further evidence of cellular changes associated with non-A, non-B hepatitis. J Med Virol 5:63–71
Tsiquaye KN, Portmann B, Tovey G, Kessler H, Shanlian H, Xiao-zhen L, Zuckerman AJ, Craske J, Williams R (1983) Non-A, non-B hepatitis in persistent carriers of hepatitis B virus. J Med Virol 11:79–89
Vidano C (1970) Phases of maize rough dwarf virus multiplication in the vector Laodelphax striatellus. Virology 41:218–232
Wyke RJ, Tsiquaye KN, Thornton A, White Y, Portmann B, Das PK, Zuckerman A J, Williams R (1979) Transmission of non-A, non-B hepatitis to chimpanzees by factor IX concentrates after fatal complications in patients with chronic liver disease. Lancet 1:520–524
Yoshizawa H, Akahane Y Itoh Y, Iwakiri S, Kitajima K, Morita M, Tanaka A, Nojiri T, Shimizu M, Miyakawa Y, Mayumi M (1980) Virus-like particles in a plasma fraction (fibrinogen) and in the circulation of apparently healthy blood donors capable of inducing non-A, non-B hepatitis in humans and chimpanzees. Gastroenterology 79:512–520
Yoshizawa H, Itoh Y, Iwakiri S, Kitajima K, Tanaka A, Nojiri T, Miyakawa Y, Mayumi M (1981) Demonstration of two different types of non-A, non-B hepatitis by reinjection and cross-challenge studies in chimpanzees. Gastroenterology 81:107–113
Yoshizawa H, Itoh Y, Iwakiri S, Kitajima K, Tanaka A, Tachibana T, Nakamura T, Miyakawa Y, Mayumi M (1982) Non-A, non-B (type 1) hepatitis agent capable of inducing tubular ultrastructures in the hepatocyte cytoplasm of chimpanzees: inactivation by formalin and heat. Gastroenterology 82:502–506
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bradley, D.W. (2000). Studies of Non-A, Non-B Hepatitis and Characterization of the Hepatitis C Virus in Chimpanzees. In: Hagedorn, C.H., Rice, C.M. (eds) The Hepatitis C Viruses. Current Topics in Microbiology and Immunology, vol 242. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59605-6_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-59605-6_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64047-6
Online ISBN: 978-3-642-59605-6
eBook Packages: Springer Book Archive